Business / Corporate Apr 3, 2017
Astellas to acquire Belgian drug-discovery firm for up to €800 million
Astellas Pharma Inc. said Monday it will acquire a full stake in Belgian clinical-stage drug-discovery firm Ogeda SA for up to €800 million ($854 million). The purchase is part of the Tokyo-based pharmaceutical company's strategy to strengthen its long-term growth by buying out firms with ...